Connect to other sites within the UBM Medica Network
Antipsychotics in Treatment-Resistant Schizophrenia
Is clozapine still the gold standard for treatment-resistant schizophrenia?
Introduction: Working With Patients Who Have Eating Disorders
An introduction to our 2-part Special Report on eating disorders, including neurobiology of eating disorders, nutritional needs of patients, clinical response to psychosis, and more.
Neurobiology of Eating Disorders: Clinical Implications
New insights into neural pathways that play a role in anorexia nervosa, bulimia nervosa, and binge eating disorder.
Understanding Nutritional Needs of Patients With Eating Disorders: Implications for Psychiatrists
Eating disorders are second only to substance-abuse disorders in having the highest mental illness mortality rate. How do we assist the patient in moving forward?
Eating Disorders and Psychosis
What is the clinical response to the occasional presence of psychotic symptoms among patients with eating disorders?
Reproductive Safety of Second-Generation Antipsychotics
Do atypical antipsychotics increase the risk of major malformations among exposed infants?
Cyberbullying and College Students: What Can Be Done?
Clinicians have a powerful voice that can be used to address cyberbullying, improve campus climate, and support a positive undergraduate experience.
Autism Spectrum Disorders, Down Syndrome, and 22q Deletion Syndrome
Treatment strategies for late-life manifestations of neurodevelopmental disorders.
In This Issue: Volume 33, No. 3
Check out what's new in schizophrenia research, personality disorders, patient education, integrative psychiatry, addiction, and more.
Addiction Psychiatry: Laws, Guidelines, and Suggestions
Clinical traditions are important, but they can become ossified as the “right way to treat addiction.” So, we need to turn a sharp, skeptical eye on treatment models.
By clicking Accept, you agree to become a member of the UBM Medica Community.